Улаанбаатар
Partnership offer put forth for Stanford University in combating liver cancer
Society
Ulaanbaatar /MONTSAME/. Parliament Speaker G.Zandanshatar received delegates led by professor at Stanford University, Director of Center for Hepatitis and Liver Tissue Engineering Jeffrey S. Glenn, President of the Hepatic Doctors’ Society of Mongolia, Dr. and Prof. Ya.Dagvadorj, and Chair of the Board of the ‘Onom’ Hepatic Research Foundation D.Naranbaatar on August 12.
At the start of the meeting, Chair of the Board of the ‘Onom’ Hepatic Research Foundation D.Naranbaatar briefly introduced the works being done in the framework of the ‘Whole Liver-Mongolia’ program. He said, “The number of people with the hepatitis C virus has reduced by 2.3 times (about 62,000 people were treated) in Ulaanbaatar so far. As for hepatitis B and D viruses, a new treatment is being done in 23 countries. A new clinical research is about to begin in our country.”
Noting that the number of cases for the hepatitis C virus could be lowered by even 80-90 percent if the works are continued to be done in the same rate, he requested the Speaker to give support on continuing the program.
Afterwards, professor at Stanford University, Director of Center for Hepatitis and Liver Tissue Engineering Jeffrey S. Glenn informed about his new treatment of liver cancer. He has been doing clinical research on the treatment of hepatitis B and D viruses and liver cancer for the last 30 years.
In response, the Speaker expressed his readiness to work in partnership with Stanford University and Mr. Jeffrey S. Glenn in reducing hepatic disease and liver cancer and its treatment.
During the meeting, the doctors highlighted the necessity of legal regulations in the use of alcohol, tobacco, and products containing sugar as it is one of the main causes for noncommunicable diseases, and especially hepatic disease. Speaker G.Zandanshatar said, “A workforce is currently working on developing a bill that will solve the issue of alcohol and tobacco. It is possible for us to work on the bill together.” He then continued on to say that although the number of cases for hepatitis B virus dropped since vaccinating all infants that were born after 1992, the amount of people with the disease in the age group of 40 and above is high, noting that the parliament will focus on improving the health insurance system in the near future.
